Abstract
The endothelium modulates vascular tone by the release of vasodilator and vasoconstrictor substances, among them nitric oxide (NO) and endothelin (ET). Abnormalities in NO generation have been demonstrated in various cardiac pathophysiological states, specifically atherosclerotic vascular disease, congestive heart failure, and essential and pulmonary hypertension. Moreover, increases in plasma ET has been reported as well in these disease states. When these observations are taken together, these states may be characterized by an attenuated release of NO, whereas the release of ET is augmented. An imbalance between NO and ET may contribute to the alteration in vascular tone characteristic of cardiovascular disease. The following review summarizes the present knowledge of the role of NO and ET in such disease processes with a major focus on coronary endothelial dysfunction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Burnett, J. Coronary endothelial dysfunction in the hypertensive patient: from myocardial ischemia to heart failure. J Hum Hypertens 11, 45–49 (1997). https://doi.org/10.1038/sj.jhh.1000400
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1000400
Keywords
This article is cited by
-
Endothelin-1 in hypertensive patients with ischemic heart disease
Internal and Emergency Medicine (2019)